Literature DB >> 11395295

Renal function and renal disease in the elderly: Part II.

W J. Mulder1, H F.P. Hillen.   

Abstract

In all industrialized countries, life expectancy has risen in the past 100 years. The incidence of elderly patients reaching end-stage renal disease (ESRD) and requiring renal replacement therapy has also increased. During the past few decades, the pattern of ESRD has changed significantly with the emerging predominance of elderly patients. The causes of this phenomenon are manifold and include an increasing number of chronic diseases typical of the 'third age', such as type 2 diabetes mellitus and vascular disease. In many species, a consequence of aging includes deterioration of renal function, partly due to structural alterations, and partly as the result of a diminishing blood flow. In humans, the aging kidney is characterized by modifications resulting from organic and functional disturbances. In particular, type 2 diabetes mellitus has emerged as an important condition, the microvascular and macrovascular complications of which are a common cause of morbidity and mortality in older patients. In Part II of this review, the specific aspects of renal replacement therapy in the elderly will be discussed.

Entities:  

Year:  2001        PMID: 11395295     DOI: 10.1016/s0953-6205(01)00128-5

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  2 in total

Review 1.  The aging kidney: a review -- part I.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 2.  Efficacy and safety of metformin in the management of type 2 diabetes mellitus in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing.

Authors:  Lisa Schlender; Yolanda V Martinez; Charles Adeniji; David Reeves; Barbara Faller; Christina Sommerauer; Thekraiat Al Qur'an; Adrine Woodham; Ilkka Kunnamo; Andreas Sönnichsen; Anna Renom-Guiteras
Journal:  BMC Geriatr       Date:  2017-10-16       Impact factor: 3.921

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.